Microcirculation in Hypertension: An Update on Clinical Significance and Therapy

被引:25
|
作者
Tsioufis, Costas [1 ]
Dimitriadis, Kyriakos [1 ]
Katsiki, Niki [2 ]
Tousoulis, Dimitris [1 ]
机构
[1] Univ Athens, Hippocrat Hosp, Cardiol Clin 1, Athens, Greece
[2] Aristotle Univ Thessaloniki, Hippocrat Hosp, Propedeut Dept Internal Med 2, Sch Med, GR-54006 Thessaloniki, Greece
关键词
Hypertension; microcirculation; small arteries resistance; cardiovascular events; antihypertensive drugs; SMALL-RESISTANCE ARTERIES; TO-LUMEN RATIO; ANGIOTENSIN-ALDOSTERONE SYSTEM; SUBCUTANEOUS SMALL ARTERIES; ANTIHYPERTENSIVE TREATMENT; CAPILLARY RAREFACTION; VASCULAR RAREFACTION; RETINAL ARTERIOLES; BLOOD-PRESSURE; STRUCTURAL ALTERATIONS;
D O I
10.2174/1570161113666150206110512
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Essential hypertension is closely related to alterations of the microcirculation as evidenced by increased media-to-lumen ratio of small resistance arteries and capillary rarefaction. It has been proposed that microvasculature alterations can further deteriorate target organ damage under the influence of increased hemodynamic load in hypertension. More than a decade ago, small artery structure was found to be the most potent predictor of cardiovascular events in essential or secondary hypertension. Amelioration of resistance vessel structure by antihypertensive drugs showed a clear benefit when patients were treated with calcium antagonists and renin-angiotensin-aldosterone inhibitor regimens. Well-designed controlled studies are needed to address the important questions whether different antihypertensive agent combinations could be related to diverse microcirculatory "responses" in terms of structure and function.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 50 条